SIGHT SCIENCES, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $77.4M | $79.9M | $81.1M | $71.3M | $49.0M | $27.6M |
| Cost of Revenue | — | $10.7M | $11.6M | $11.9M | $12.4M | $8.6M | $9.2M |
| Gross Profit | — | $66.7M | $68.3M | $69.2M | $59.0M | $40.3M | $18.4M |
| Gross Margin | — | 86.2% | 85.5% | 85.3% | 82.7% | 82.4% | 66.7% |
| Operating Expenses | |||||||
| Research & Development | — | $14.6M | $18.0M | $17.6M | $22.9M | $15.6M | $8.9M |
| SG&A Expense | — | $89.2M | $100.8M | $108.9M | $120.1M | $76.2M | $41.7M |
| Operating Income | — | $-37.1M | $-50.5M | $-57.3M | $-84.0M | $-51.5M | $-32.2M |
| Operating Margin | — | -48.0% | -63.3% | -70.7% | -117.7% | -105.2% | -116.5% |
| Interest Expense | — | $5.1M | $4.7M | $5.4M | $4.5M | $4.4M | $2.4M |
| Pretax Income | — | $-38.4M | $-51.3M | $-55.4M | $-86.2M | $-62.8M | $-34.6M |
| Income Tax Expense | — | $10.0K | $236.0K | $110.0K | $47.0K | $188.0K | $61.0K |
| Net Income | — | $-38.4M | $-51.5M | $-55.5M | $-86.2M | $-63.0M | $-34.7M |
| Net Margin | — | -49.7% | -64.5% | -68.5% | -120.9% | -128.6% | -125.5% |
| EPS (Basic) | — | $-0.74 | $-1.03 | $-1.14 | $-1.80 | $-2.36 | $-3.71 |
| EPS (Diluted) | — | $-0.74 | $-1.03 | $-1.14 | $-1.80 | $-2.36 | $-3.71 |
| Shares Outstanding (Basic) | 54.0M | 52.1M | 50.1M | 48.6M | 47.8M | 26.7M | 9.5M |
| Shares Outstanding (Diluted) | 54.0M | 52.1M | 50.1M | 48.6M | 47.8M | 26.7M | 9.5M |
| Dividends Per Share | — | — | — | — | — | — | — |